{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/endometriosis/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"9493bc31-622c-53a5-8b99-0bb65dfcfbdf","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 5763be99-fdf9-405c-91e7-dbe0837ee821 --><h2>Changes</h2><!-- end field 5763be99-fdf9-405c-91e7-dbe0837ee821 -->","summary":null,"htmlStringContent":"<!-- begin item 743b9944-960c-4a4c-9bb5-08eda8b60c79 --><!-- begin field 08e1bf89-124c-4030-a727-ca1d5d74e181 --><p><strong>February 2020 </strong>— reviewed. A literature search was conducted in February 2020 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. The topic has been updated in line with the National Institute for Health and Care Excellence (NICE) guideline <em>Endometriosis: diagnosis and management </em>[NICE, 2017].</p><!-- end field 08e1bf89-124c-4030-a727-ca1d5d74e181 --><!-- end item 743b9944-960c-4a4c-9bb5-08eda8b60c79 -->","topic":{"id":"3eef2de4-2956-51b1-a059-4cbd4139a25b","topicId":"b292df1a-ddc5-4a1d-9b90-185ea19b4e70","topicName":"Endometriosis","slug":"endometriosis","lastRevised":"Last revised in February 2020","chapters":[{"id":"395e6ee5-6371-5176-836b-781aff9c04d6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b283df94-e1ac-5c31-8754-e01a285248de","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6975b1f3-b77b-52cf-8b4d-5c6b3fc69c98","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"9493bc31-622c-53a5-8b99-0bb65dfcfbdf","slug":"changes","fullItemName":"Changes"},{"id":"d7bf8cc4-e8cc-5257-b824-cb3ddacabce7","slug":"update","fullItemName":"Update"}]},{"id":"f446ba22-a9c2-56c4-878c-b0b0bdac1aff","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a00e7a73-6f58-5c74-bd34-16e7e1cc4e24","slug":"goals","fullItemName":"Goals"},{"id":"1ab4c596-bae4-587c-924f-0eef167e7c05","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"206d9666-9c0e-5d1e-8396-df764b62eed0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ac09dd77-b858-58e3-b26f-fa304d1cf972","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fbdbef3c-8dff-5a5a-9053-b45b6d8131c2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2e5f6c6e-45b7-569c-a5e3-c22ba3b58f9e","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3a1a2e88-04ae-5e36-959d-dc6038a6add8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b120ad25-5b10-5fb6-bb61-6cb7b7a3cc6d","slug":"definition","fullItemName":"Definition"},{"id":"a4d25028-c2aa-590a-b300-ac339d386deb","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"7fc7c903-bdb8-527f-8d3f-e6f7351f9ce5","slug":"prevalence","fullItemName":"Prevalence"},{"id":"295d176b-2a42-5aab-9041-597768d69e04","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"91b98eb3-9399-51c0-b3a9-f217fb27b632","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6e69ef3a-c9fc-5125-8f0d-b3de4181871c","slug":"when-to-suspect-endometriosis","fullItemName":"When to suspect endometriosis"},{"id":"27e4bc58-6ffc-59dc-827f-c9bd03efc267","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"ff4f77ef-f0bb-591c-8c52-fc7fe9121986","fullItemName":"Management","slug":"management","subChapters":[{"id":"3ac6ca53-459b-5a16-bc24-873902024f55","slug":"management-of-endometriosis","fullItemName":"Scenario: Management of endometriosis"}]},{"id":"7aefc621-a490-5c6a-accf-f5de72607d6e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fce9f6b2-26c8-535a-9876-e67581d932f1","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"13ae1af5-15e0-5e27-ba71-571e1b01f9f0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7618ad57-5ba3-52d3-aaeb-901bee04142c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"985b51b0-bbeb-5a26-b82e-79c117fd707c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8b78290d-3b22-53b9-9d50-2d7f5163f6cf","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"05170929-c3a6-50cc-9097-47768e1a7162","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4d2cb436-2e08-5f24-b0e1-7c76956521c1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6975b1f3-b77b-52cf-8b4d-5c6b3fc69c98","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"d91ec829-2f10-590b-b839-2c42aef73440","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 8490a814-cdc3-482f-88c5-31e57ec269da --><h3>Previous changes</h3><!-- end field 8490a814-cdc3-482f-88c5-31e57ec269da -->","summary":null,"htmlStringContent":"<!-- begin item d6463006-415b-4775-98b0-540e5b81fe5c --><!-- begin field 286176dc-8c4a-4b4e-9c20-9485fb6626cb --><p><strong>March to May 2014 </strong>— reviewed. A literature search was conducted in February 2014 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. Only one significant change has been made to this topic:</p><ul><li>Codeine has been removed as an analgesia treatment option. There is no evidence that weak opioids are effective for the treatment of endometriosis-associated dysmenorrhoea, and expert opinion published in a guideline by the Royal College of Obstetricians and Gynaecologists (RCOG) states that as a result of the chronic nature of dysmenorrhoea, potentially addictive analgesics should be avoided [<a class=\"bibliography-reference internal-reference\" href=\"/topics/endometriosis/references/\">RCOG, 2012</a>].</li></ul><p><strong>July 2013 </strong>— minor update. Update to the text to reflect recent advice from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding diclofenac.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>October 2010 </strong>— minor update. From mid-October 2010, Nexplanon<sup>® </sup>will replace Implanon<sup>®</sup>. Nexplanon<sup>® </sup>is bioequivalent to Implanon<sup>®</sup>. The main differences are that Nexplanon<sup>®  </sup>is radio-opaque, and the insertion technique is different. Issued in October 2010.</p><p><strong>September 2010 </strong>— minor update. A prescription for Rigevidon<sup>®</sup>, another new ethinylestradiol plus levonorgestrel combined oral contraceptive pill, has been added. Issued in September 2010.</p><p><strong>June 2010 </strong>— minor update. A prescription for Levest<sup>®</sup>, a new ethinylestradiol plus levonorgestrel combined oral contraceptive pill, has been added. Issued in June 2010.</p><p><strong>February to June 2009 </strong>— converted from CKS guidance to CKS topic structure. The evidence base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations.</p><p><strong>February 2009 </strong>— minor update. Dydrogesterone tablets no longer available in the UK. Prescriptions removed. The upper age limits on the combined oral contraceptive pill prescriptions have been reduced to 50 years. Issued in March 2009.</p><p><strong>January to March 2006 </strong>— reviewed. Validated in June 2006 and issued in July 2006.</p><p><strong>October 2005 </strong>— minor technical update. Issued in November 2005.</p><p><strong>August 2002 </strong>— reviewed. Validated in December 2002 and issued in February 2003.</p><p><strong>July 1999 </strong>— written. Validated in October 1999 and issued in January 2000.</p><!-- end field 286176dc-8c4a-4b4e-9c20-9485fb6626cb --><!-- end item d6463006-415b-4775-98b0-540e5b81fe5c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}